01 1Viatris
01 1DOLUTEGRAVIR SODIUM
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2016-01-26
Pay. Date : 2015-11-24
DMF Number : 30011
Submission : 2015-11-26
Status : Active
Type : II
20
Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is DOLUTEGRAVIR SODIUM, with a corresponding US DMF Number 30011.
Remarkably, this DMF maintains an Active status since its submission on November 26, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 26, 2016, and payment made on November 24, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II
